Experience

Awarded for his contribution to innovative advances in the field of Radiation Oncology, Dr. Drew Moghanaki is a reference in the treatment of Lung Cancer. He specializes in advanced techniques such as Intensity Modulated Radiation Therapy to offer more precise, effective and less invasive treatments to his patients. In this sense, he has performed his work in reference health institutions such as UCLA Health in California, United States.

He has also been a pioneer in the implementation of Stereotactic Body Radiotherapy for Lung Tumors. Through this technique, he has managed to increase survival rates and significantly optimize the quality of life of numerous users. It has also developed a multidisciplinary approach in the management of Neoplasms, which has helped specialists to design personalized treatments to improve their clinical results. On the other hand, he has managed more than 50 million dollars in Lung Cancer program development through the U.S. Department of Veterans Affairs. His initiatives have been instrumental in driving progress in diagnosis, treatment and access to high quality care for people who have served in the Armed Forces.

Committed to excellence, he balances this work with his role as a clinical researcher. In this sense, he has published numerous scientific articles on subjects such as Magnetic Resonance Guided Radiotherapy. One of his most outstanding works is the VALOR trial, focused on the analysis of the effectiveness of surgery and Stereotactic Radiotherapy in Lung Cancer. Thanks to this, physicians have obtained solid scientific evidence to make informed decisions about the best approach for the treatment of this pathology taking into account the specific characteristics of the patients. In addition, he participates as a speaker at scientific congresses to discuss the latest innovations in Radiation Oncology.

  • Chief of the Thoracic Oncology Service at UCLA Health, California, United States
  • Director of Clinical Research at the U.S. Department of Veterans Affairs
  • Director of Pulmonary Precision Oncology at the West Los Angeles VA Medical Center
  • Section Chief of Radiation Oncology at VA Greater Los Angeles Health System
  • Chair of Diagnostic Research Team at UCLA Jonsson Comprehesive Cancer Center
  • Radiation Epidemiology Oncology Residency at the University of Pennsylvania
  • General Surgery Internship at Vanderbilt University Medical Center
  • M.D. from Vanderbilt University School of Medicine
  • Master's Degree in Public Health and Epidemiology from University of California
  • Bachelor of Science degree in Biochemistry from California Polytechnic State University.
  • Member of: 
    • American Cancer Society
    • American Society for Radiosurgery
    • International Association for the Study of Lung Cancer
Programmes in collaboration with

1 /